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SUMMARY
Some cutaneous melanocytic lesions arc notoriously difficult to diagnose by histopathology. For that reason, the Pathology Panel of 
the Dutch Melanoma Working Party was instituted and is regularly approached to provide an expert opinion on problem cases. In order 
to identify the most common diagnostic problems, 1069 consecutive referral cases of submitted lesions (1992 to 1994 inclusive) were 
analysed. About 60 per cent of the requests came from small laboratories, with up to three consultant pathologists. Two-thirds of the 
lesions reviewed concerned women and nearly 50 per cent of the patients were 30 years of age or younger. In 8 per cent of the cases, the 
referring pathologists felt unable to make a confident diagnosis; in 14 per cent, melanoma was suspected; and in 12 per cent, a differential 
diagnosis only had been formulated. The panel felt able to provide an unequivocal diagnosis in 93 per cent of the requests. Of the 158 
lesions classified as ‘invasive melanoma’ by the referring pathologists, 22 were considered to be benign by the panel. Conversely, 108 
invasive melanomas (panel diagnosis) had originally been considered as benign lesions, dysplastic naeyi or melanoma in situ. These high 
numbers of discordancies reflect the intrinsic difficulty of the differential diagnoses in this selected material submitted to the panel. 
Diagnostic difficulties were most often encountered with Spitz naevi and dysplastic naevi. Although the rate of ovcrdiagnosis and 
underdiagnosis is quite high, in the majority of cases the diagnosis of the referring pathologist matched the diagnosis of the panel This 
may reflect a proper awareness of difficult melanocytic lesions in pathology practice. The activities of the Pathology Panel of the Dutch 
Melanoma Working Party contribute to the improvement of the quality of diagnosis in cutaneous melanocytic lesions, as they increase 
the number of unequivocal diagnoses and reduce the number of incorrect diagnoses. On the basis of the systematic comparison of the 
diagnosis by the referring pathologist and the panel, postgraduate teaching and quality control can be more focused on specific diagnostic 
problems. ©  1997 by John Wiley & Sons, Ltd,
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INTROD UCTION
Quality assurance is of great importance in the diag­
nosis and treatm ent of cancer patients. This is under­
scored by the current policy of various international 
organizations which stimulate quality control projects in 
different aspects of the management of cancer patients. 
As an example, in the field of cutaneous melanoma, 
quality control within the framework of the EORTC 
(European Organization for Research and Treatment of 
Cancer) melanoma cooperative group is executed in the 
context of clinical trials, i.e., by means of site visits by an 
expert surgeon to centres which have patients entered 
treated with isolated perfusion therapy .1 W ith regard to
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the histological diagnosis and micro-staging of lesions 
from patients entered in such studies and others, quality 
assurance is pursued by the reviewing of the slides by 
expert pathologists.
High quality standards within the framework of inter­
national collaboration are not possible without a con­
tinuous effort to maintain and improve the care of 
melanoma patients at the national and regional level. 
Thus, melanoma working parties are now active in 
several countries, including The Netherlands. The Dutch 
Melanoma W orking Party was founded in 1986. It 
consists of a multi-disciplinary forum of the various 
specialties involved in melanoma management, aiming 
at improving the prevention, early diagnosis, and treat­
ment of melanoma. Three consensus texts on melanoma 
were prepared by the group under the guidance of the 
National Organization for Quality Assurance in 
Hospitals.2 Members of the working party also act 
as consultants for colleagues with less experience in
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Table I—Categorization of separate diagnoses into diagnostic categories
Separate diagnosis Category
No diagnosis No diagnosis
Common acquired naevus (CAN) Common acquired naevus (CAN)
Spitz naevus Spitz naevus
Congenital naevus Other special type of naevus
Pigmented spindle cell naevus Other special type of naevus
Blue naevus Other special type of naevus
Combined naevus Other special type of naevus
Dysplastic naevus Dysplastic naevus
Lentigo maligna Melanoma in situ
Melanoma in situ Melanoma in situ
Melanoma in situ with dysplastic naevus Melanoma in situ
Suspicion of malignant melanoma Suspected melanoma
Superficial spreading melanoma Invasive melanoma
Nodular melanoma Invasive melanoma
Lentigo maligna melanoma Invasive melanoma
Acral lentiginous melanoma Invasive melanoma
Melanoma unclassified Invasive melanoma
Melanoma in congenital naevus Invasive melanoma
Melanoma in pre-existing naevus Invasive melanoma
Melanoma metastasis Invasive melanoma
Differential diagnosis Differential diagnosis
Other diagnosis Other
m elanom a diagnosis. In addition, the working party 
provides continuous education in melanoma pathology. 
In o rder to make such efforts as effective as possible, 
insight is required into the problems encountered by 
pathologists. This is of importance since it provides 
subjects for targeted training.
A bou t 300 cases are sent annually to the Pathology 
Panel o f  the Dutch Melanoma Working Party for expert 
opinion. The purpose of this article is to report on a 
consecutive series of 1069 such cases, with emphasis on 
the specific diagnostic problems and major discrepancies 
between the diagnoses o f referring pathologists and 
panel pathologists. Recommendations are made with 
respect to  targeted quality control and continuous
education.
/ ?
PATIENTS, MATERIALS, AND METHODS
Working methods of the Pathology Panel and materials
The Pathology Panel of the Dutch Melanoma W ork­
ing Party  consists of three pathologists (WJM, D JR , and 
ES). It operates on a consultative basis: pathologists 
who have difficulties in making an unequivocal diagnosis 
o f  a lesion may send representative slides and/or paraffin 
blocks o f  the lesion along with a tentative diagnosis to a 
m em ber o f the panel. The referring pathologist receives 
a written report from the panel member within 1 week. 
W here doub t remains, the panel member may send the 
slides to  other panel members. The cases are discussed 
am ong the panel members at regular bi-monthly meet­
ings. Very occasionally, this panel discussion leads to a
©  1997 by John Wiley & Sons, Ltd.
clinically relevant change in the original panel diagnosis, 
which is then prom ptly communicated in an additional 
report.
Requests are received from pathologists throughout 
The N etherlands and occasionally from abroad. Each 
consultation is recorded in the national computerized 
system for pathological diagnoses (Pathologisch A nato­
misch Landelijk Geautomatiseerd Archief, PALGA) 
which facilitates retrieval o f follow-up data. From each 
consultation, data  are collected by registering items 
through a standard list: gender, date of birth, site o f the 
lesion, name of the hospital/department of the referring 
colleague, name of the pathologist consulted, diagnosis 
of the referring pathologist, available material, and 
panel diagnosis. The panel members use information 
mentioned in the report and the accompanying letter 
from the referring pathologist to complete this list.
The diagnoses o f the referring pathologists and the 
panel pathologist(s) are registered as standard entities 
listed in Table I. For this study, these entities were 
grouped into the following categories: no diagnosis, 
common acquired naevus (CAN), Spitz naevus, other 
special type of naevus, dysplastic naevus, melanoma 
in situ , suspected melanoma, invasive melanoma, and 
others. The category ‘differential diagnosis’ was also 
included.
Methods used for evaluation of the data
Com parison of the referring pathologists’ and the 
panel’s diagnoses was m ade in terms of overdiagnosis 
and underdiagnosis.
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All lesions
Panel diagnosis 
‘invasive melanoma’
c? 9 c? 9
389 (37%) 658 (63%) 120 (34%) 237 (66%)
Age (years)
0-15 74 (19%) 56 (9%) 7 (6%) 5 (2%)
16-30 101 (26%) 215 (33%,) 20 (17%) 49 (21 %)
31^5 95 (25%) 201 (31%o) 38 (32%)) 78 (33%,)
46-60 62 ( 16%) 107 (16%) 28 (24%) 58 (24%)
61-75 36 (9%) 59 (9%) 14 (12%) 37 (16%)
75 + 18 (5%) 14 (2%) 12 (10%) 10 (4%)
Unknown 3 6 1
Gender unknown 22 7
sent in 179 cases (median: 12.5; range: 2-61). Thus, small 
institutes with fewer pathologists sent in more cases.
Age and gender o f the patients
in  Table II the distribution of gender and age of all 
submitted cases and of the cases with a panel diagnosis 
o f ‘invasive m elanom a’ are presented. About two-thirds 
o f all submitted cases concerned women and nearly half 
o f the patients were 30 years of age or younger. The 
younger the age, especially in children, the more lesions 
that were submitted, but few invasive melanomas were 
identified by the panel in childhood cases (Table II). 
Nevertheless, the percentage of invasive melanomas in 
young individuals among the invasive melanomas diag­
nosed by the panel was high, when compared with the 
age distribution in the general population. In the panel’s 
series, about 25 per cent of invasive melanomas were 
from patients 30 years or younger, while in the Dutch 
cancer registry only about 10 per cent of invasive 
melanoma patients are under the age of 30.3 This reflects 
the particular difficulties encountered by pathologists in 
diagnosing lesions in younger patients, as well, perhaps, 
as a reluctance to diagnose invasive melanoma in a 
young patient w ithout seeking a second opinion. Of the 
submitted cases in male patients younger than 16 years 
of age, 9 per cent (7 of 74) were diagnosed as invasive 
melanoma, whereas the corresponding figure was 67 per 
cent (12 of 18) in patients over 75 years o f age (Table II).
W ith regard to gender, the panel diagnosed more 
cases o f invasive m elanom a in females than in males, 
compared with the general population: 34 per cent males 
and 66 per cent females diagnosed by the panel against 
41 per cent and 59 per cent respectively, in the general 
population .3 This m ay be due to the overall surplus of 
lesions from females submitted for consultation.
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Overdiagnosis was defined from the perspective of 
clinical relevance, including therapeutic consequences. 
The following situations were regarded as overdiagnosis: 
the diagnostic category of the referring pathologist was 
‘suspected m elanom a’ or ‘invasive m elanom a’, while the 
diagnostic category o f the panel was 'common acquired 
naevus’, 'Spitz naevus’, 'special type of naevus\ ‘dys- 
plastic naevus’ or ‘m elanom a in s itu \
Underdiagnosis was defined as the situation in which 
lesions were classified as ‘common acquired naevus’, 
‘Spitz naevus’, ‘special type of naevus’, ‘dysplastic nae­
vus’ or ‘melanoma in situ by the referring pathologist 
and as ‘suspected m elanom a5 or ‘invasive m elanom a’ by 
the panel.
RESULTS
The Pathology Panel examined a total num ber o f 1069 
cases over a 3 year period: 333 in 1992, 359 in 1993, and 
377 in 1994.
Referring pathologist
The requests came from pathologists working in hos­
pitals or institutes th roughout The Netherlands and 
from some pathologists abroad (8 cases in 1992, 24 cases 
in 1993, and 24 cases in 1994). The num ber o f requests 
per institute varied from 1 to 35 per year. F our institutes 
sent 15 or more cases per year. The institutes were 
grouped according to  the num ber of pathologists 
into the following categories: small institutes ( 1-3  path­
ologists); intermediate (4-6 pathologists); large (> 6  
pathologists); and unknown. Thirty-five small institutes 
over the 3 year period submitted 614 cases (median: 30; 
range: 1-88), 14 ‘interm ediate’ institutes sent in 194 
cases (median: 13; range: 2-33) and ten large institutes
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Table III—Diagnosis of the referring pathologist versus diagnosis of the Pathology Panel
Diagnosis of
referring
pathologist
Pathology Panel
No
diagn.1 CAN2
Spitz
naevus
Special
naevus3
Dyspl.
naevus4
Mel.
i.s.5 Suspected
Invasive
m el6 Diff,7 Other Total
No diagnosis 1 8 21 12 12 3 6 21 2 4 90
Comm. acq. naevus8 0 48 5 12 3 2 1 11 1 1 84
Spitz naevus 0 2 109* 11 2 0 8 17 5 3 157
Special naevus3 1 1 3 39 0 1 3 4 2 0 54
Dysplastic naevus 1 24 16 20 56 13 9 35 2 0 176
Melanoma in situ 1 1 1 1 5 16 2 18 1 0 46
Suspected melanoma 2 11 25 8 8 3 16 71 4 3 151
Invasive melanoma 0 3 10 4 2 3 2 133 1 0 158
Diff. diagnosis9 1 5 34 15 11 4 3 51 5 2 131
Other 0 0 1 4 0 0 0 3 0 14 22
Total 7 103 225 126 99 45 50 364 23 27 1069
The bold numbers represent those cases for which the diagnostic category of the referring pathologist matched that of the panel.
1 No diagn.: no diagnosis.
2 CAN: common acquired naevus.
3 Special naevus: other special type of naevus.
4 Dyspl. naevus: dysplastic naevus.
5 Mel. i.s.: melanoma in situ.
6 Invasive meL: invasive melanoma.
7 Diff: differential diagnosis.
8 Comm. acq. naevus: common acquired naevus.
9 Dift’. diagnosis: differential diagnosis.
Site o f  the lesion
The site o f the lesion was recorded in 692 cases. The 
most com m on sites, in decreasing order of frequency, 
were legs 34 per cent (234); trunk 33 per cent (226); 
head/neck region 17 per cent (115); arms 12 per cent 
(85); and other sites 5 per cent (32). Other sites included 
conjunctiva ( 11), external genitals (10), juxtacutaneous 
mucosa (5), hip (1), abdominal cavity (3), lumbar spinal 
column ( 1), and lymph node (1).
Of the 364 lesions diagnosed by the panel as invasive 
melanoma, the sites were trunk 35 per cent (83); legs 32 
per cent (76); head/neck region 19 per cent (44); arms 10 
per cent (24); and other localizations 3 per cent (8 ). The 
site was unknow n in 129 cases.
The body distribution of the invasive melanomas 
diagnosed by the panel was compared with the lesions 
coded in 1993 as invasive melanoma in the national 
computerized system PALGA. The distribution o f the 
sites o f the lesions in PALGA was legs 43 per cent (98); 
trunk 30 per cent (67); head/neck region 13 per cent (30); 
and arm s 14 per cent (32). Compared with the distri­
bution seen in the general invasive melanoma popu ­
lation, the panel invasive melanoma cases were 
somewhat less often localized on the legs and more often 
in the head/neck region, This may reflect a tendency to 
seek confirm ation of the diagnosis of invasive m elanom a 
preferentially in the head/neck region, since its impact in 
terms o f  surgical treatment and cosmetic consequences is 
greater th an  a t other sites.
©  1997 by John Wiley & Sons, Ltd.
Diagnosis
Table III presents the diagnoses o f the referring 
pathologist versus the diagnoses o f the panel, after 
categorization, Relatively many of the lesions referred 
were diagnosed by the panel as Spitz naevus or other 
special types o f naevus. The referring pathologists 
submitted many lesions with suspicion of malig­
nancy, bu t few lesions with a diagnosis of ‘melanoma 
in situ'.
From the total number o f lesions categorized as 
'o ther’ by the referring pathologist or the panel (22+27), 
a substantial number were classified as nou-melanocytic 
soft tissue tum our (20), melanocytic lesion of the 
conjunctiva (8), or melanocytic tum our not specified 
in the other mentioned categories (8). A  final group o f 13 
lesions consisted of various other diagnoses, such as 
‘scar’ and ‘dermatitis1.
The total number of lesions in which the panel felt 
unable to arrive at a diagnosis was 7; five lesions were 
represented by a punch biopsy and two others had been 
mechanically damaged.
In 23 cases in which the panel had no t reached 
an unequivocal diagnosis, the following differential 
diagnoses were given: Spitz naevus versus invasive 
melanoma (7); (dysplastic) naevus versus invasive m ela­
nom a (6); other special type of naevus versus invasive 
melanoma (5); m elanom a in situ versus invasive 
melanoma (1). In four instances, other differential 
diagnoses were reported,
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Panel
No Differential Invasive
Referring pathologist diagnosis Benign17DN2/MIS3 diagnosis Suspected melanoma Total
No diagnosis 1 56 2 6 21 86
Benign VDN2/MIS3 3 391 11 23 85 513
Differential diagnosis 1 69 5 3 51 129
Suspected melanoma 2 55 4 16 71 148
Invasive melanoma 0 22 1 2 133 158
Total 7 593 23 50 361 1034
The bold numbers represent those cases for which the diagnostic category of the referring pathologist matched that of the panel. 
’Lesions included: common acquired naevus, Spitz naevus, other special type of naevus.
2DN: dysplastic naevus.
3MIS: melanoma in situ*
Lesions classified as ‘other’ were excluded in this table.
O f the 90 lesions without a referring pathologist’s 
diagnosis the panel made an unequivocal diagnosis in 81 
cases, including 21 of invasive melanoma. Of the 131 
lesions with a differential diagnosis by the referring 
pathologist, the panel had an unequivocal diagnosis 
in 122 cases, including 51 of invasive melanoma. Of the
151 lesions with the referring diagnosis ‘suspected 
m elanom a5, the panel made an unequivocal diagnosis in 
129 cases, including 71 of invasive melanoma.
Overdiagnosis and underdiagnosis were defined and 
calculated from  a perspective of clinical relevance, 
including therapeutic consequences (see the Materials 
and M ethods section).
Over diagnosis
O f the 151 lesions classified by the referring pathol­
ogist as suspected melanoma, (Table III), 55 lesions were 
overdiagnosed. Here it was taken into account that 
lesions classified in a pathology report as 'suspected 
m elanom a’ will probably be regarded and treated by 
clinicians as if they were invasive melanoma. The panel 
classified 11 cases as common acquired naevus, 25 as 
Spitz naevus, 8 as other special type of naevus, 8 as 
dysplastic naevus, and 3 as melanoma in situ . Of the 158 
lesions classified by the referring pathologist as invasive 
melanoma, 22 lesions were overdiagnosed. The panel 
classified 3 cases as common acquired naevus, 10 as 
Spitz naevus, 4 as other special type of naevus, 2 as 
dysplastic naevus, and 3 as melanoma in situ .
Under diagnosis
O f the 84 lesions classified by the referring pathologist 
as common acquired naevus (Table III), 12 were classi­
fied by the panel as ‘suspected melanoma5 or invasive 
melanoma. The numbers o f the other underdiagnosed 
lesions were Spitz naevus, 25 of 157; other special type of 
naevus, 7 o f 54; dysplastic naevus, 44 of 176; and 
melanoma in situ , 20 of 46.
Table IV presents a summary of the diagnostic cat­
egories of referring pathologists versus panel pathol­
ogists) with the further grouping of diagnoses based on 
clinical relevance.
DISCUSSION
Although the large majority of melanocytic tumours 
o f the skin do not present significant diagnostic prob­
lems, a small minority of lesions are very difficult to 
diagnose .4" 6 An expert pathological diagnosis of such 
cases may be of great clinical importance. In the present 
study, in 8 per cent (90) of the lesions submitted, the 
referring pathologists could not provide a confident 
diagnosis; in 14 per cent (151) there was suspicion of 
melanoma, while in a further 12 per cent (131) only a 
differential diagnosis had been formulated. In these 372 
lesions, the panel was able to make an unequivocal 
diagnosis in 332 cases. It classified 7 per cent (25) as 
suspected melanoma and 38 per cent (143) as invasive 
melanoma.
It is unclear how many cases of overdiagnosed in­
vasive melanoma really occur in practice. In the present 
study, overdiagnosis as ‘suspected melanoma5 was 
recorded in 55 of 151 cases and as ‘invasive melanoma1 
in 22 of 158 cases. In the case of a diagnosis of 
‘suspected melanoma5, a second opinion is always likely 
to be requested, as no certainty is given. In contrast, an 
incorrect but unequivocal diagnosis of invasive 
melanoma will not usually be submitted for pathology 
review, generally leading to overtreatment of the patient. 
Nevertheless, although an unequivocal diagnosis of 
invasive melanoma was reported by the referring path­
ologist in 22 cases, there must have been some element 
o f doubt with regard to the diagnosis, since otherwise, 
the case would not have been submitted for consulta­
tion.
A lthough the number of discordant diagnoses is quite 
high, the majority of diagnoses of the referring pathol­
ogists matched those of the panel. This might indicate a
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proper awareness of difficult cases in practice. The only 
approach to come up with hard data, however, is a 
systematic comparison of all diagnoses. In a docum en­
tation study of melanomas in one regional D utch com” 
prehensive cancer centre (Integraal Kankercentrum 
Oost), all invasive melanomas and melanomas in situ are 
reviewed by a member of the panel (DJR). O f the first
152 lesions, only one case diagnosed as lentigo maligna 
was classified by the panel member as common acquired 
naevus and  three cases reported as melanoma in situ 
were diagnosed by the panel member as superficial 
spreading melanoma. These numbers are quite reassur­
ing, regard ing  the quality of the diagnosis. A t the 
national level, the use of the Dutch PALGA system 
makes it possible to review, at a later stage, cases of 
‘thick’ invasive melanomas which had not metastasized .7 
Since m ost o f  the metastatic lesions will be verified 
histologically, a proportion of those thick invasive 
m elanom as without documented metastases m ay be 
overdiagnosed naevi. These approaches may become a 
part o f an integrated quality control programme in the 
future.
U nderdiagnosis of invasive melanoma as a benign 
lesion was noted in this study in 13-25 per cent of the 
cases: 12 o f 84 common acquired naevus; 25 of 157 Spitz 
naevus; 7 o f 54 other special type of naevus; 44 o f 176 
dysplastic naevus; and 20 of 46 melanoma in situ . Again, 
a lthough  these figures on discordant cases are quite 
high, the  majority of the cases were concordant. This 
p robab ly  reflects a low threshold to submit cases to the 
panel and  a proper identification of die group of difficult 
lesions.
A m a jo r problem in estimating the true num ber of 
underd iagnosed  melanocytic lesions in general practice 
is the fact th a t most thin misdiagnosed invasive mela­
nom as will no t metastasize and will remain undetected 
as misclassified lesions. In a recent search for underdiag­
nosed cases covering about 10 years in The Netherlands, 
using the PA L G A  system, only a few cases o f truly 
proven invasive melanoma 'misdiagnosed’ as Spitz nae­
vus were uncovered .8 However, it remains unclear how 
m any cases m ay have been given another key diagnosis 
in  the com puterized system, after a case being recog­
nized as a  ‘misdiagnosis’, e.g., after metastasis,
M any lesions were diagnosed by the panel as Spitz 
naevus o r  as another special type of naevus. In addition, 
o f  the 23 lesions with a differential diagnosis given by the 
panel, seven lesions concerned the diagnosis Spitz nae- 
vus versus invasive melanoma, six lesions the diagnosis 
(dysplastic) naevus versus invasive melanoma, and five 
lesions the diagnosis other special type of naevus versus 
invasive m elanom a. Obviously, both referring pathol­
ogists and  panel pathologists have difficulties in diagnos­
in g  such lesions.£|_6'9’H) In terms of improving the general 
level o f  accuracy in melanoma diagnosis, it would 
a p p e a r  to be m ost effective to concentrate postgraduate 
ed u ca tio n  on the specific problems concerning dysplastic 
naevus and  Spitz naevus. A teaching slide set composed 
3f  difficult cases could be circulated among laboratories 
m cl discussed with an expert. During such discussions, 
h e  technical quality of histological slides could also 
ye addressed. A t a later stage, test slide sets could be
j) 1997 by John Wiley & Sons, Ltd.
circulated in order to evaluate the diagnostic skill o f the 
participating pathologists. Also, quality m onitoring may 
focus on the problems mentioned. Local laboratories, 
in consultation with more experienced colleagues in 
difficult cases, can select representative lesions (i.e., not 
classical, but without a reason for consultation) for a 
second opinion (intra- or inter-institutional).
The procedure of consultation by individual pane! 
members only is a result o f the relatively large num ber of 
cases submitted and the need for a rapid response. A 
prom pt response is greatly appreciated by both the 
referring pathologist and the clinician. For this reason, 
an independent opinion by all panel members on all 
cases is not feasible, As a compromise, only selected 
cases, which are considered difficult by the reviewing 
panel member, are sent to the other members for further 
evaluation. In addition, the regular panel meetings prove 
very useful in fine-tuning the histopathological criteria 
and their interpretation. In almost every case a consen­
sus could be reached, although this does not always 
mean an unequivocal diagnosis. In fact, the panel, for 
mainly technical reasons, was no t able to make a 
diagnosis in seven cases and could make only a differ­
ential diagnosis in 23 cases and a diagnosis of ‘suspected 
melanoma' in 50 cases. Here, molecular techniques may 
provide relevant additional diagnostic information,
In this article, the diagnosis of the panel is assumed to 
be the correct diagnosis. We realize that the panel too is 
susceptible to misinterpretation or observer bias. H ow ­
ever, based on the specific experience acquired in this 
particular field of pathology, the panel is more likely to 
change wrong diagnoses into correct ones than the other 
way around. Cases diagnosed as melanoma in situ or 
invasive melanoma are m onitored through the cancer 
registry, which will enable clinical validation of the panel 
diagnosis. In addition, cases diagnosed as benign with 
a later presentation of melanoma metastasis can be 
traced systematically through the pathology databank
PALGA.
So far, there has been no opportunity to perform an 
inter-observer study among all panel members on sub­
mitted, or otherwise selected, difficult cases. However, in 
a recent extended inter-observer study on melanocytic 
lesions among ten (dermato)pathologists in the melano­
cytic field in Europe, the best overall inter-observer 
agreement was between two members of the panel who 
participated in that study . 11 Furtherm ore, in an earlier 
independent review of a set of 104 melanocytic lesions 
(not especially difficult cases), the pair-wise inter­
observer agreement among the three panel members was 
good (agreement >95 per cent and kappa >0.80, unpub­
lished results, PEJ dW) compared with other studies. 
Even so, an inter-observer study on the lesions received 
for consultation as described here needs to be per­
formed, as this is a specific subgroup of cases. The 
lesions are difficult to diagnose, more often located 
in the head and neck region, and the patients tend 
to be younger. Such a study may yield more specific 
information on the problems encountered in this area o f 
pathology.
In this article, the diagnoses of referring pathologists 
and the Pathology Panel o f the D utch M elanom a
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W orking Party were compared. The rates o f overdiag­
nosis and underdiagnosis (together with incorrect trea t­
ment) are shown to be quite high. There is no reason to 
believe that such rates o f diagnostic problems exist only 
in The Netherlands. Difficulties in diagnosing melano- 
cytic lesions are well known in the international litera­
ture, 4" 6’9-10 but they are described in a more qualitative 
manner. In the 3 years analysed, the panel received some 
requests from  pathologists abroad, amongst which 
misdiagnoses were also found.
In summary, our data indicate tha t a second opinion 
given by pathologists experienced in the diagnosis o f 
cutaneous melanocytic lesions is useful for diagnostic 
quality assurance. Uncertainty in the assessment of 
diagnoses and over- or under-diagnosis are serious p rob­
lems that deserve to receive continuous attention. The 
quality of melanoma pathology can be improved by 
expert review and by continuing education targeted at 
the specific problems signalled.
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